Vancomycin-resistant Enterococcus faecium endocarditis in a premature infant successfully treated with linezolid

被引：34

作者：

Ang, JY ^{[1
]}

Lua, JL

Turner, DR

Asmar, BI

机构：

[1] Childrens Hosp Michigan, Detroit, MI 48201 USA

[2] Wayne State Univ, Sch Med, Div Infect Dis, Detroit, MI USA

[3] Wayne State Univ, Sch Med, Div Neonatol, Detroit, MI USA

[4] Wayne State Univ, Sch Med, Div Cardiol, Detroit, MI USA

来源：

PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2003年 / 22卷 / 12期

关键词：

vancomycin-resistant enterococcus; endocarditis; neonate; linezolid;

D O I：

10.1097/01.inf.0000101784.83146.0c

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

A 4(1)/(2)-month-old, 26-week premature infant with multiple complications of prematurity required a central venous catheter for venous access and antibiotic treatment of bacterial nosocomial infections. He developed tricuspid valve endocarditis with vegetation caused by Enterococcus faecium resistant to ampicillin, vancomycin and quinupristin-dalfopristin but susceptible to linezolid. He was successfully treated with linezolid intravenously (7 weeks) and then orally (2 weeks).

引用

页码：1101 / 1103

页数：3

共 20 条

[1] Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid
Babcock, HM
Ritchie, DJ
Christiansen, E
Starlin, R
Little, R
Stanley, S
[J]. CLINICAL INFECTIOUS DISEASES, 2001, 32 (09) : 1373 - 1375
[2] Linezolid for the treatment of multidrug-resistant, gram-positive infections: Experience from a compassionate-use program
Birmingham, MC
Rayner, CR
Meagher, AK
Flavin, SM
Batts, DH
Schentag, JJ
[J]. CLINICAL INFECTIOUS DISEASES, 2003, 36 (02) : 159 - 168
[3] Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant enterococcus
Carmeli, Y
Eliopoulos, GM
Samore, MH
[J]. EMERGING INFECTIOUS DISEASES, 2002, 8 (08) : 802 - 807
[4] Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections
Chien, JW
Kucia, ML
Salata, RA
[J]. CLINICAL INFECTIOUS DISEASES, 2000, 30 (01) : 146 - 151
[5] STREPTOCOCCUS-FAECIUM OUTBREAK IN A NEONATAL INTENSIVE-CARE UNIT
COUDRON, PE
MAYHALL, CG
FACKLAM, RR
SPADORA, AC
LAMB, VA
LYBRAND, MR
DALTON, HP
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1984, 20 (06) : 1044 - 1048
[6] Oxazolidinone antibiotics
Diekema, DJ
Jones, RN
[J]. LANCET, 2001, 358 (9297) : 1975 - 1982
[7] DOBSON SRM, 1990, PEDIATRICS, V85, P165
[8] ANTIMICROBIAL SUSCEPTIBILITY PATTERNS OF COMMON AND UNUSUAL SPECIES OF ENTEROCOCCI CAUSING INFECTIONS IN THE UNITED-STATES
GORDON, S
SWENSON, JM
HILL, BC
PIGOTT, NE
FACKLAM, RR
COOKSEY, RC
THORNSBERRY, C
JARVIS, WR
TENOVER, FC
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (09) : 2373 - 2378
[9] Linezolid treatment of vancomycin-resistant Enterococcus faecium ventriculitis
Graham, PL
Ampofo, K
Saiman, L
[J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2002, 21 (08) : 798 - 800
[10] Multiple-drug resistant Enterococci: The nature of the problem and an agenda for the future
Huycke, MM
Sahm, DF
Gilmore, MS
[J]. EMERGING INFECTIOUS DISEASES, 1998, 4 (02) : 239 - 249

← 1 2 →